T1	Outcomes 1486 1544	progression rate and freedom from treatment failure (FFTF)
T2	Outcomes 1608 1626	24-month FFTF rate
T3	Outcomes 1702 1721	progressive disease
T4	Outcomes 1765 1788	Differences in survival
T5	Outcomes 1838 1872	acute toxicity of baseline BEACOPP
